Literature DB >> 8008223

Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration.

W F Stewart1, A Shechter, R B Lipton.   

Abstract

Data from population-based studies are summarized to characterize the full range and variability of the impact migraine has on the individual. Despite differences in methods and data collection in population-based studies describing disability, pain intensity, and attack frequency as well as the duration of migraine and other headaches, several patterns emerge. On average, migraine headaches are more disabling, more painful, and longer in duration than other types of headaches. Females report more pain and disability with headache than do males. Although disability measurements are important in demonstrating the effect of headache on both the individual and society, actual measurements often fall short. Most studies use only workdays lost as the sole measure of disability. Most migraineurs do not miss work while experiencing a headache; instead, they attempt to function on the job, with considerably reduced effectiveness. Computing only workdays lost does not account for impairment at work nor does it show the impact of migraine on other aspects of life. In addition, evidence suggests the presence of a pain intensity threshold for disability. Headache-related pain intensity below the threshold is not associated with disability. Despite the threshold of pain intensity for disability, a significant proportion of migraine sufferers report levels of pain intensity above the threshold in the absence of work-related disability. The grading of headache severity should be a composite that would permit a more complete image of the heterogeneity of migraine's effects and a more accurate idea of the need for healthcare services. This composite should include two areas: (1) more complete measures of life impact, encompassing daily activities in a number of domains, including work, family, and social activities; and (2) an assessment of pain intensity and attack frequency.

Entities:  

Mesh:

Year:  1994        PMID: 8008223

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  48 in total

1.  Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons.

Authors:  Jamie Bellamy; Elizabeth J Bowen; Andrew F Russo; Paul L Durham
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

Review 2.  Prophylactic migraine therapy: emerging treatment options.

Authors:  Marcelo E Bigal; Abouch V Krymchantowski; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2004-06

Review 3.  Diagnosing migraine in the pediatric population.

Authors:  Paul Winner; Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 4.  Childhood periodic syndromes and migraine.

Authors:  Paul Winner
Journal:  Curr Pain Headache Rep       Date:  2005-06

Review 5.  Migraine with aura: conventional and non-conventional treatments.

Authors:  Giovanni D'Andrea; Davide Colavito; Maurizio Dalle Carbonare; Alberta Leon
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

6.  Acute Treatment of Migraine Headache.

Authors:  Marcelo E. Bigal; Richard B. Lipton
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

7.  Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons.

Authors:  Paul L Durham; Andrew F Russo
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

8.  The responsiveness of headache impact scales scored using 'classical' and 'modern' psychometric methods: a re-analysis of three clinical trials.

Authors:  M Kosinski; J B Bjorner; J E Ware; A Batenhorst; R K Cady
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

9.  Calibration of an item pool for assessing the burden of headaches: an application of item response theory to the headache impact test (HIT).

Authors:  Jakob B Bjorner; Mark Kosinski; John E Ware
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

10.  Diagnosing and managing headache in children.

Authors:  Paul Winner; Scott W Powers; Marielle A Kabbouche; Andrew D Hershey
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.